Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 5:23 pm Purchase | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | BlackRock Inc. BLK | 24,642,666 9.200% | 6,108,207 (+32.96%) | Filing History |
| 2024-01-10 10:16 am Purchase | 2023-12-29 | 13G | Pacific Biosciences of California, Inc. PACB | The Vanguard Group | 26,789,499 10.020% | 6,510,464 (+32.10%) | Filing History |
| 2023-02-13 4:03 pm Purchase | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Madrone Capital Partners, LLC | 19,915,933 8.800% | 3,000,000 (+17.73%) | Filing History |
| 2023-02-13 3:54 pm Sale | 2023-02-14 | 13G | Pacific Biosciences of California, Inc. PACB | Capital International Investors | 6,099,681 2.700% | -6,006,637 (-49.62%) | Filing History |
| 2023-02-10 1:48 pm Sale | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 25,691,681 11.360% | -691,422 (-2.62%) | Filing History |
| 2023-02-10 10:29 am Purchase | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Amova Asset Management Americas, Inc. | 14,166,193 6.260% | 2,251,168 (+18.89%) | Filing History |
| 2023-02-09 7:12 pm Sale | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Jackson Square Partners LLC | 15,005,177 6.640% | -7,418,738 (-33.08%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Pacific Biosciences of California, Inc. PACB | The Vanguard Group | 20,279,035 8.970% | 424,159 (+2.14%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | BlackRock Inc. BLK | 18,534,459 8.200% | 1,965,215 (+11.86%) | Filing History |
| 2023-02-03 06:10 am Purchase | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Sumitomo Mitsui Trust Group, Inc. | 14,166,193 6.260% | 2,251,168 (+18.89%) | Filing History |
| 2022-06-01 4:00 pm Purchase | 2022-03-15 | 13G | Pacific Biosciences of California, Inc. PACB | Madrone Capital Partners, LLC | 16,915,933 7.500% | 16,915,933 (New Position) | Filing History |
| 2022-02-14 06:05 am Purchase | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Amova Asset Management Americas, Inc. | 11,915,025 5.400% | 11,915,025 (New Position) | Filing History |
| 2022-02-11 11:20 am Purchase | 2022-02-14 | 13G | Pacific Biosciences of California, Inc. PACB | Capital International Investors | 12,106,318 5.500% | 2,298,292 (+23.43%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | The Vanguard Group | 19,854,876 9.000% | 5,534,577 (+38.65%) | Filing History |
| 2022-02-09 2:45 pm Sale | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 26,383,103 11.960% | -2,121,526 (-7.44%) | Filing History |
| 2022-02-04 8:55 pm Purchase | 2022-01-31 | 13G | Pacific Biosciences of California, Inc. PACB | Jackson Square Partners LLC | 22,423,915 10.170% | 8,949,477 (+66.42%) | Filing History |
| 2022-02-04 06:09 am Purchase | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Sumitomo Mitsui Trust Group, Inc. | 11,915,025 5.400% | 11,915,025 (New Position) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | BlackRock Inc. BLK | 16,569,244 7.500% | 1,453,754 (+9.62%) | Filing History |